November 14, 2017 6:20pm

Thirty four (34) as of today ... so far

Financial results also known as (AKA) earnings are a ‘scorecard’ of public stem, cell, gene and regenerative therapy's companies.




The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.